Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

NCT04457089 is registered in ClinicalTrials.gov with Marc Goodman as lead sponsor.

NCT NCT04457089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04457089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer
Lead sponsor
Marc Goodman
Phase
Phase 1
Overall status
Completed
Start date
January 25, 2021
Completion date
May 12, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

platinum-sensitive ovarian cancer, recurrent ovarian cancer